Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.336 USD | -91.91% | +37.65% | -25.50% |
Sales 2024 * | 65.3M 88.98M | Sales 2025 * | 6.25M 8.52M | Capitalization | 20.65M 28.15M |
---|---|---|---|---|---|
Net income 2024 * | 26M 35.43M | Net income 2025 * | -40M -54.51M | EV / Sales 2024 * | 0.32 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.3 x |
P/E ratio 2024 * |
0.86
x | P/E ratio 2025 * |
-0.54
x | Employees | 46 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.3% |
Latest transcript on MEI Pharma, Inc.
1 day | -91.91% | ||
1 week | +37.65% | ||
Current month | +42.16% | ||
1 month | +34.13% | ||
3 months | -2.72% | ||
6 months | -26.07% | ||
Current year | -25.50% |
Managers | Title | Age | Since |
---|---|---|---|
David Urso
CEO | Chief Executive Officer | 60 | 14-03-06 |
Justin File
DFI | Director of Finance/CFO | 53 | 23-06-11 |
Caroline Ruiz
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 73 | 18-02-25 |
Thomas Reynolds
BRD | Director/Board Member | 65 | 13-02-10 |
Charles Baltic
CHM | Chairman | 63 | 11-10-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 3.14 | -.--% | 451 |
24-05-22 | 3.14 | -0.63% | 160 |
Delayed Quote London S.E., March 01, 2023 at 09:35 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+44.98% | 40.65B | |
-10.87% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- MEIP Stock
- 0JW9 Stock